Impact Biomedical, Stock Investor Sentiment
| IBO Stock | USD 1.85 0.08 4.15% |
About 61% of Impact BioMedical,'s investor base is looking to short. The analysis of the overall investor sentiment regarding Impact BioMedical, suggests that many traders are alarmed. Impact BioMedical,'s investing sentiment overview a quick insight into current market opportunities from investing in Impact BioMedical,. Many technical investors use Impact BioMedical, stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Impact |
Far too much social signal, news, headlines, and media speculation about Impact BioMedical, that are available to investors today. That information is available publicly through Impact media outlets and privately through word of mouth or via Impact internal channels. However, regardless of the origin, that massive amount of Impact data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Impact BioMedical, news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Impact BioMedical, relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Impact BioMedical,'s headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Impact BioMedical, alpha.
Impact BioMedical, Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Disposition of 500 shares by Dss, Inc. of Impact BioMedical, at 2.757 subject to Rule 16b-3 | 11/12/2024 |
2 | Disposition of 200 shares by Dss, Inc. of Impact BioMedical, at 2.8 subject to Rule 16b-3 | 11/13/2024 |
3 | Disposition of 5000 shares by Dss, Inc. of Impact BioMedical, at 3.017 subject to Rule 16b-3 | 11/18/2024 |
4 | Acquisition by Heuszel Frank D of 550 shares of Impact BioMedical, at 2.625 subject to Rule 16b-3 | 11/26/2024 |
5 | Acquisition by Heuszel Frank D of 500 shares of Impact BioMedical, at 2.61 subject to Rule 16b-3 | 11/27/2024 |
6 | Acquisition by Heuszel Frank D of 500 shares of Impact BioMedical, at 2.2578 subject to Rule 16b-3 | 12/05/2024 |
7 | Discretionary transaction by Dss, Inc. of tradable shares of Impact BioMedical, subject to Rule 16b-3 | 01/06/2025 |
Check out Impact BioMedical, Hype Analysis, Impact BioMedical, Correlation and Impact BioMedical, Performance. To learn how to invest in Impact Stock, please use our How to Invest in Impact BioMedical, guide.You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Impact BioMedical,. If investors know Impact will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Impact BioMedical, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Impact BioMedical, is measured differently than its book value, which is the value of Impact that is recorded on the company's balance sheet. Investors also form their own opinion of Impact BioMedical,'s value that differs from its market value or its book value, called intrinsic value, which is Impact BioMedical,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Impact BioMedical,'s market value can be influenced by many factors that don't directly affect Impact BioMedical,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Impact BioMedical,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Impact BioMedical, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Impact BioMedical,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.